Mirabegron Extended-Release Tablets, 25 mg, 30-count bottle, Rx only, Manufactured by: Zydus Lifesciences Ltd., Matoda, Ahmedabad, India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, Recall

Ongoing
Drugs
Class II — Moderate

Recall Date

Aug 12, 2026

Company

Zydus Pharmaceuticals (USA) Inc

Source

FDA

Reason: CGMP: Due to Out of Specification (OOS) result for N-Nitroso Mirabegron impurity.

Class II: Use of the product may cause temporary or medically reversible health problems.

Official FDA recall notice

Information is from official FDA notices. Do not stop taking any medication without consulting your doctor or pharmacist first — the risks of stopping may be greater than the risk from the recalled product.

Recall Details

Description

CGMP: Due to Out of Specification (OOS) result for N-Nitroso Mirabegron impurity.

Reason for Recall

CGMP: Due to Out of Specification (OOS) result for N-Nitroso Mirabegron impurity.

Product: Mirabegron Extended-Release Tablets, 25 mg, 30-count bottle, Rx only, Manufactured by: Zydus Lifesciences Ltd., Matoda, Ahmedabad, India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington,
Official Recall ID: FDA-DRUG-D-0745-2026

What Should I Do?

Check your lot number. Don't stop taking a prescribed medication without talking to your pharmacist or doctor. Contact the pharmacy where you got it about a replacement.

Remediation GuideAction Required

5-step guide to help you action required this recalled product. Click Start Remediation to track your progress.

1
Confirm Your Product Is Affected
2
Read the Full Recall Notice
3
Stop Using the Product if in Doubt

+2 more steps…

View Official Recall Notice (FDA)

Last updated August 18, 2026

More recalls from Zydus Pharmaceuticals (USA) Inc

Similar recalls

Injured by a recalled product?

Our legal partners offer free consultations for recall victims.

Get Free Legal Help →Sponsored

Stay Informed

Weekly recall digest — free, no spam.